Short-term prediction of mortality in patients with systemic lupus erythematosus: classification of outcomes using random forests.
暂无分享,去创建一个
Sinisa Pajevic | Michael M Ward | James D Malley | J. Malley | S. Pajevic | M. Ward | J. Dreyfuss | Jonathan Dreyfuss
[1] F Alemi,et al. Predicting In-Hospital Survival of Myocardial Infarction: A Comparative Study of Various Severity Measures , 1990, Medical care.
[2] M. Pine,et al. Using Clinical Variables to Estimate the Risk of Patient Mortality , 1991, Medical care.
[3] Hude Quan,et al. Validity of Information on Comorbidity Derived From ICD-9-CCM Administrative Data , 2002, Medical care.
[4] A. Wiik,et al. Systemic lupus erythematosus. Follow-up study of 148 patients. II: Predictive factors of importance for course and outcome , 1987, Clinical Rheumatology.
[5] J. Fries,et al. Variables associated with decreased survival in systemic lupus erythematosus. , 1991, Seminars in Arthritis & Rheumatism.
[6] G. Szegedi,et al. Systemic lupus erythematosus survival in Hungary. Results from a single centre. , 1999, Clinical and experimental rheumatology.
[7] S. Studenski,et al. Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes. , 1995, Arthritis and rheumatism.
[8] C. Lau,et al. A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population. , 2000, Rheumatology.
[9] J. Reveille,et al. Systemic lupus erythematosus in three ethnic groups. VIII. Predictors of early mortality in the LUMINA cohort , 2001 .
[10] M. Ward,et al. Mortality and causes of death in systemic lupus erythematosus , 2001, Current opinion in rheumatology.
[11] M. Ward,et al. Hospitalizations for coronary artery disease among patients with systemic lupus erythematosus. , 2003, Arthritis and rheumatism.
[12] D. Wallace,et al. Systemic lupus erythematosus--survival patterns. Experience with 609 patients. , 1981, JAMA.
[13] D. Mark,et al. Bias in the coding of hospital discharge data and its implications for quality assessment. , 1994, Medical care.
[14] J. Fries,et al. A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. , 1982, Arthritis and rheumatism.
[15] R. Deyo,et al. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.
[16] G. Hughes,et al. Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period: A Comparison of Early and Late Manifestations in a Cohort of 1,000 Patients , 2003, Medicine.
[17] E Lucero,et al. Systemic lupus erythematosus: mortality and survival in Argentina. A multicenter study. , 2000, Lupus.
[18] T. Harrer,et al. Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus , 2002, Annals of the rheumatic diseases.
[19] D. Alarcón-Segovia,et al. Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus. , 1994, The Journal of rheumatology.
[20] D. Gladman,et al. Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus , 2001, Lupus.
[21] Jodi B Segal,et al. Accuracy of identification of patients with immune thrombocytopenic purpura through administrative records: A data validation study , 2004, American journal of hematology.
[22] D. Isenberg,et al. SLICC/ACR Damage Index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus. , 1996, British journal of rheumatology.
[23] L. Villarroel,et al. Survival of Chilean patients with systemic lupus erythematosus. , 1994, Seminars in arthritis and rheumatism.
[24] S. Studenski,et al. Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus. , 1996, Archives of internal medicine.
[25] D. Gladman,et al. Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality. , 1995, The Journal of rheumatology.
[26] J. Gómez-Reino,et al. Survival analysis of 306 European Spanish patients with systemic lupus erythematosus , 1998, Lupus.
[27] R. Tamblyn,et al. Validation of diagnostic codes within medical services claims. , 2004, Journal of clinical epidemiology.
[28] E L Hannan,et al. Clinical Versus Administrative Data Bases for CABG Surgery: Does it Matter , 1992, Medical care.
[29] L. Roos,et al. Risk adjustment in claims-based research: the search for efficient approaches. , 1989, Journal of clinical epidemiology.
[30] M Pine,et al. Predictions of Hospital Mortality Rates: A Comparison of Data Sources , 1997, Annals of Internal Medicine.
[31] O. Nived,et al. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus. , 2002, The Journal of rheumatology.
[32] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[33] D. Gladman,et al. Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity. , 2000, The Journal of rheumatology.
[34] M. Vilardell,et al. Contribution of the initial features of systemic lupus erythematosus to the clinical evolution and survival of a cohort of Mediterranean patients , 2003, Annals of the rheumatic diseases.
[35] J. Reveille,et al. Prognosis in systemic lupus erythematosus , 1990 .
[36] M. Ward. Development and testing of a systemic lupus-specific risk adjustment index for in-hospital mortality. , 2000, The Journal of rheumatology.
[37] A. Voss,et al. A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value , 2005, Clinical Rheumatology.